About Us Services Careers FAQ Contact Us 0
Home Medical Devices Smart Insulin or Glucose Responsive Insulin Market Size, Share and Forecast to 2031
Smart Insulin or Glucose Responsive Insulin Market

Smart Insulin or Glucose Responsive Insulin Market Size, Share & Trends Analysis Report By Delivery Device (Smart Insulin Pens, Smart Insulin Pumps), By Disease (Type 1 Diabetes, Type 2 Diabetes), By End-User (Rapid-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Short-Acting Insulin, Premixed-Type Insulin) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD54216DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Smart Insulin or Glucose Responsive Insulin Market Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    1. Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    5. U.S.
      1. By Delivery Device
        1. Introduction
          1. Delivery Device By Value
        2. Smart Insulin Pens
          1. By Value
        3. Smart Insulin Pumps
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Type 1 Diabetes
          1. By Value
        3. Type 2 Diabetes
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rapid-Acting Insulin
          1. By Value
        3. Intermediate-Acting Insulin
          1. By Value
        4. Long-Acting Insulin
          1. By Value
        5. Short-Acting Insulin
          1. By Value
        6. Premixed-Type Insulin
          1. By Value
    6. Canada
    1. Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    5. U.K.
      1. By Delivery Device
        1. Introduction
          1. Delivery Device By Value
        2. Smart Insulin Pens
          1. By Value
        3. Smart Insulin Pumps
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Type 1 Diabetes
          1. By Value
        3. Type 2 Diabetes
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rapid-Acting Insulin
          1. By Value
        3. Intermediate-Acting Insulin
          1. By Value
        4. Long-Acting Insulin
          1. By Value
        5. Short-Acting Insulin
          1. By Value
        6. Premixed-Type Insulin
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    5. China
      1. By Delivery Device
        1. Introduction
          1. Delivery Device By Value
        2. Smart Insulin Pens
          1. By Value
        3. Smart Insulin Pumps
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Type 1 Diabetes
          1. By Value
        3. Type 2 Diabetes
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rapid-Acting Insulin
          1. By Value
        3. Intermediate-Acting Insulin
          1. By Value
        4. Long-Acting Insulin
          1. By Value
        5. Short-Acting Insulin
          1. By Value
        6. Premixed-Type Insulin
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    5. UAE
      1. By Delivery Device
        1. Introduction
          1. Delivery Device By Value
        2. Smart Insulin Pens
          1. By Value
        3. Smart Insulin Pumps
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Type 1 Diabetes
          1. By Value
        3. Type 2 Diabetes
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rapid-Acting Insulin
          1. By Value
        3. Intermediate-Acting Insulin
          1. By Value
        4. Long-Acting Insulin
          1. By Value
        5. Short-Acting Insulin
          1. By Value
        6. Premixed-Type Insulin
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Delivery Device
      1. Introduction
        1. Delivery Device By Value
      2. Smart Insulin Pens
        1. By Value
      3. Smart Insulin Pumps
        1. By Value
    3. By Disease
      1. Introduction
        1. Disease By Value
      2. Type 1 Diabetes
        1. By Value
      3. Type 2 Diabetes
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rapid-Acting Insulin
        1. By Value
      3. Intermediate-Acting Insulin
        1. By Value
      4. Long-Acting Insulin
        1. By Value
      5. Short-Acting Insulin
        1. By Value
      6. Premixed-Type Insulin
        1. By Value
    5. Brazil
      1. By Delivery Device
        1. Introduction
          1. Delivery Device By Value
        2. Smart Insulin Pens
          1. By Value
        3. Smart Insulin Pumps
          1. By Value
      2. By Disease
        1. Introduction
          1. Disease By Value
        2. Type 1 Diabetes
          1. By Value
        3. Type 2 Diabetes
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rapid-Acting Insulin
          1. By Value
        3. Intermediate-Acting Insulin
          1. By Value
        4. Long-Acting Insulin
          1. By Value
        5. Short-Acting Insulin
          1. By Value
        6. Premixed-Type Insulin
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Smart Insulin or Glucose Responsive Insulin Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Adocia
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca
    3. Diamesco CO. LTD.
    4. B. Braun Melsungen
    5. Becton
    6. F. Hoffmann-LA Roche Ltd.
    7. Dickinson and Company
    8. Biocon
    9. Biodel
    10. Bioton
    11. Novo Nordisk A/S Dongbao Enterprise Group
    12. Tandem Diabetes Care INC
    13. Medtronic PLC.
    14. Eli Lilly and Company
    15. GSK.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.